Share

Volanesorsen Shown to Reduce Triglyceride Levels in Patients with Severe Hypertriglyceridemia

Last month, our team presented data showing apolipoprotein C-III (apoC-III) inhibition with a RNA-targeted antisense therapy called volanesorsen effectively lowered triglycerides in patients with hypertriglyceridemia by 70%. This data was presented today at the National Lipid Association annual meeting in Philadelphia. Volanesorsen is designed to reduce the production of apoC-III, a protein produced in the...
Share

Pancreas Donors: A Key to a Diabetes Cure?

pancreas-donor If you haven’t heard of the JDRF Network for the Pancreatic Organ Donors with Diabetes aka nPOD, you will. nPOD is not just a research lab or a clearing house for pancreas tissue from donors with diabetes, it’s on the front lines to finding a cure. Last December, during the International Diabetes Federation World Diabetes...
Share

FCS Support Group Launched

A group of concerned patients and care providers for a rare disease have announced the formation of the first-ever organization dedicated to providing education and support for people living with familial chylomicronemia syndrome (FCS), a rare and potentially life-threatening genetic lipid disorder. The FCS Foundation will provide a range of educational materials and support services...
Share

A New Hope? Reevaluating Pancreatectomy for Chronic Pancreatitis

Once considered a “last resort” in patients with chronic pancreatitis, a new study shows that a total pancreatectomy with islet autotransplantation, sooner rather than later, can stave off the onset of diabetes and improve quality of life. A diagnosis of chronic pancreatitis (CP) once doomed a patient to significantly diminished quality of life (QOL) at...